| __timestamp | Celldex Therapeutics, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 4733600000 |
| Thursday, January 1, 2015 | 100171000 | 4796400000 |
| Friday, January 1, 2016 | 102726000 | 5243900000 |
| Sunday, January 1, 2017 | 96171000 | 5281800000 |
| Monday, January 1, 2018 | 66449000 | 5051200000 |
| Tuesday, January 1, 2019 | 42672000 | 5595000000 |
| Wednesday, January 1, 2020 | 42534000 | 6085700000 |
| Friday, January 1, 2021 | 53311000 | 7025900000 |
| Saturday, January 1, 2022 | 82258000 | 7190800000 |
| Sunday, January 1, 2023 | 118011000 | 9313400000 |
| Monday, January 1, 2024 | 14271000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Eli Lilly and Company and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, reflecting a robust commitment to innovation, with spending peaking at over $9.3 billion in 2023. In contrast, Celldex Therapeutics, while showing a 13% increase in R&D spending over the same period, maintained a more modest investment, with expenditures reaching approximately $118 million in 2023. This disparity highlights Eli Lilly's aggressive strategy in pioneering new treatments, while Celldex adopts a more cautious approach. As the pharmaceutical landscape continues to shift, these investment strategies will play a crucial role in shaping the future of healthcare.
Research and Development Expenses Breakdown: Eli Lilly and Company vs GSK plc
Research and Development Investment: Eli Lilly and Company vs Sanofi
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
Comparing Innovation Spending: Eli Lilly and Company and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
Analyzing R&D Budgets: Merck & Co., Inc. vs Celldex Therapeutics, Inc.
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
argenx SE or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Celldex Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and MiMedx Group, Inc.